Barry Kagan, a director of Dipexium Pharmaceuticals, Inc., just received 18,000 options from the company. The strike price of the options received was $10.16, and these expire on January 19, 2026. Kagan now owns at least 18,000 options on the company.

Some additional info was provided as follows:

Options vest as follows: 50% on the date of grant and the remaining 50% vests in equal installments over a 24 month period.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Dipexium Pharmaceuticals, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

General statement of acquisition of beneficial ownership - Nov. 20, 2017
Dipexium Pharmaceuticals, Inc. Just Filed Its Quarterly Report: Loss per share Basic... - Nov. 9, 2017
Departure of Directors or Certain - Oct. 27, 2017

Auto Refresh

Feedback